Back to results
US 2019/0290636 A1Published application
Certain chemical entities, compositions and methods
AssigneeIntellikine LLC
InventorsPingda Ren, Yi Liu, Troy Edward Wilson, Liansheng Li, Katrina Chan, Christian Rommel
Life of this patent
Estimating the term…
Abstract
Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
Claims21
1-22. (canceled)
A compound of Formula I-1:
- or a pharmaceutically acceptable salt thereof, wherein
- B is alkyl or a moiety of Formula II:
- wherein Wc is aryl, heteroaryl, heterocycloalkyl, or cycloalkyl, and
- q is an integer of 0, 1, or 2;
- X is absent or —(CH(R9))z—, and z is an integer of 1, 2, 3, or 4;
- Y is absent, —N(R9)—, or —N(R9)CH(R9)—;
- wherein at least one of X and Y is present;
- Wd is
- Ra′ is hydrogen, halo, or amino;
- R1 is hydrogen, —F, —Cl, —CN, —CH3, isopropyl, —CF3, —OCH3, nitro, or phosphate;
- R2 is halo, hydroxy, cyano, nitro, or phosphate;
- R3 is aryl, heteroaryl, H, —CH3, —CF3, —Cl, or —F;
- each R9 is independently hydrogen, methyl, or ethyl;
- and
- R12 is hydrogen, alkyl, alkynyl, alkenyl, halo, aryl, heteroaryl, heterocycloalkyl, cycloalkyl, cyano, amino, carboxylic acid, alkoxycarbonyl, or amido.
12 more elements
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.